3SOF

Hi

Hi
TA - 
Resist. - 0.02

Hi

BUYINS.NET: SHCM, ADSD Have Been On BUYINS.NET Naked Short List For 13 Consecutive Trading Days
By M2
Last Update: 10/13/2006 9:31:23 AM
Addison-Davis Diagnostics, Inc. (ADSD) primarily offers diagnostic products. Its diagnostic platform is designed for point-of-care and ambulatory use, and incorporates a single-use disposable specimen collection device. The company's desktop analyzer is capable of detecting data for Myoglobin, CK-MB, Cardiac Troponin-1, and GP-BB, as well as the presence and volume of cocaine. The analyzer can be used in clinics and doctor's offices, as well as in emergency rooms. Addison-Davis is also developing a hand-held mobile multiple assay analyzer that would incorporate the patented technology for specimen collection and provide results for various cardiac and blood-born metrics. In addition, the company engages in the development and commercialization of Drug Stop, a FDA cleared rapid urinalysis test for drugs of abuse, for professional and over-the-counter use. The company was formerly known as QT 5, Inc. and changed its name to Addison-Davis Diagnostics, Inc. in November 2004. Addison-Davis is based in Westlake Village, California. With 1.23 million shares outstanding and 5,387 shares declared short as of September 2006, the failure to deliver in shares of ADSD has not been resolved and a buy-in is imminent.

ADSD +39% 

Hi
ADSD +27% 

Hi

Hi

http://americanbulls.com/weekly/StockPage.asp?CompanyTicker=ADSD&MarketTicker=OTC&TYP=S

It will be possible here interesting game (only my opinion)

Hi
ADSD For some days above in 500% from 0.007 up to 0.035 
Yesterday and today there was a withdrawal, Supp. 0.02 $
I think ADSD will go further upwards without problems
Market Cap: 26.95K
Shares Outstanding: 1,225,000
TA optimistic (only my opinion)

 

Hi

Hi


BUYINS.NET: CTDC, IDSY, PARL, SIGM, VE, ADSDE Have Been Removed From Naked Short List Today
Wednesday, November 01, 2006 09:17 ET
Addison-Davis Diagnostics, Inc. (OTCBB: ADSDE) primarily offers diagnostic products. Its diagnostic platform is designed for point-of-care and ambulatory use, and incorporates a single-use disposable specimen collection device. The company's desktop analyzer is capable of detecting data for Myoglobin, CK-MB, Cardiac Troponin-1, and GP-BB, as well as the presence and volume of cocaine. The analyzer can be used in clinics and doctor's offices, as well as in emergency rooms. Addison-Davis is also developing a hand-held mobile multiple assay analyzer that would incorporate the patented technology for specimen collection and provide results for various cardiac and blood-born metrics. In addition, the company engages in the development and commercialization of Drug Stop, a FDA cleared rapid urinalysis test for drugs of abuse, for professional and over-the-counter use. The company was formerly known as QT 5, Inc. and changed its name to Addison-Davis Diagnostics, Inc. in November 2004. Addison-Davis is based in Westlake Village, California. With 1.23 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of ADSDE

Market Cap: 28.18K
P/E (ttm): N/A
EPS (ttm): -15.324